Praised for its ability to see ‘the forest and the trees’, Herbert Smith Freehills LLP pulls together a strong offering that includes seed financing, patent protection, commercial disputes, M&A, merger control and regulatory matters. Alan Montgomery co-leads the practice and is geared to handle a range of cross-border transactional work in the life sciences sector. Fellow co-leadChris Parker KC’s contentious expertise is frequently relied upon by major pharmaceutical clients. The ‘client-friendly’ Sebastian Moore is a known name for co-ordinating patent litigation cases across Europe. Brussels-based Kyriakos Fountoukakos frequently advises life science sector clients on M&A transactions. Andrew Wells is well-placed to handle IP enforcement strategy. R&D-based pharmaceutical companies trust Jonathan Turnbull with a range of commercial mandates.
Testimonials
Collated independently by Legal 500 research team.
‘Smart, careful, ability to see the forest and the trees. Great ability to learn complex issues. Delivers advice that makes sense for the business, not just at law.’
‘Partner Sebastian Moore is very client-friendly, responsive and easy to work with.’
Key clients
- Gilead Sciences, Inc
- AbbVie, Inc
- Roche
- Genus plc
- Abcam plc
- Biotage AB
- Johnson Matthey plc
- CSL Behring
- Sanofi
- Biogen
Work highlights
- Advising Sanofi in a number of key jurisdictions – including the UK, France, Germany, and Italy, in developing litigation strategy for its multiple sclerosis drug, Aubagio®.
- Advised Biotage AB on its acquisition of Astrea Bioseparations, a high-growth chromatography solutions provider from Gamma Biosciences.
- Advising RTW Biotech, an investment fund focused on transformative biotech and medtech companies, on its recommended all-share acquisition of Arix's assets by RTW Biotech.
Lawyers
Practice head
The lawyer(s) leading their teams.
Alan Montgomery, Chris Parker KC